Company · CIK 0001003929
VIA Pharmaceuticals, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 10-KAnnual report0000950123-11-028637 · 1.3 MBSEC(opens sec.gov)
- 8-KCurrent report0000950123-11-003476 · 54.7 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-10-107740 · 12.5 KBSEC(opens sec.gov)
- SC 13D/AVIA Pharmaceuticals, Inc.0000950123-10-106676 · 87.8 KBSEC(opens sec.gov)
- 4Insider trades0001209191-10-055481 · 12.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950123-10-105728 · 1.0 MBSEC(opens sec.gov)
- 8-KCurrent report0000950123-10-100806 · 37.1 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-10-090045 · 11.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950123-10-077890 · 671.1 KBSEC(opens sec.gov)
- 8-KCurrent report0000950123-10-069066 · 12.9 KBSEC(opens sec.gov)
Insiders
- ARIES FINANCIAL SERVICES INCInsider
- ARIES TRUSTInsider
- ATWOOD ROBERT TDirector, CFO, Executive VP
- Bagnall MarkDirector
- BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP10% Owner
- BAY CITY CAPITAL LLC10% Owner
- BOSTON SCIENTIFIC CORP10% Owner
- CALLICUTT JACK WVP-Finance&Admin, Chf Acct Off
- CHIANG YAWEN LSVP - Chief Scientific Officer
- Cohen Lawrence KennethDirector, CEO and President
Tickers
No tickers on record.
Addresses
business
750 BATTERY STREET SUITE 330
SAN FRANCISCO, CA, 94111
mailing
750 BATTERY STREET SUITE 330
SAN FRANCISCO, CA, 94111
Former names
- CORAUTUS GENETICS INC2007-06-20
- GENSTAR THERAPEUTICS CORP2002-12-19
- UROGEN CORP2000-02-14
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies